Bridges Investment Management Lowered By $303,610 Its Biogen Com (BIIB) Stake; Era Group Has 1.43 Sentiment

Bridges Investment Management Inc decreased Biogen Inc Com (BIIB) stake by 7.88% reported in 2017Q3 SEC filing. Bridges Investment Management Inc sold 970 shares as Biogen Inc Com (BIIB)’s stock declined 13.45%. The Bridges Investment Management Inc holds 11,340 shares with $3.55M value, down from 12,310 last quarter. Biogen Inc Com now has $60.50B valuation. The stock decreased 0.34% or $0.97 during the last trading session, reaching $285.98. About 881,660 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since March 7, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Era Group Inc. provides helicopter transportation services primarily to the gas and oil exploration, development, and production companies. The company has market cap of $213.29 million. The Company’s helicopter services include emergency response search and rescue; air medical services; Alaska flightseeing tours; and other services, as well as utility services to support firefighting, mining, VIP transport, power line, and pipeline survey activities. It currently has negative earnings. The firm also leases helicopters to third parties and foreign affiliates; engineers, makes, and distributes after-market helicopter parts and accessories; and provides classroom instruction, flight simulator, and other training services.

The stock increased 6.04% or $0.57 during the last trading session, reaching $10. About 64,000 shares traded or 1.24% up from the average. Era Group Inc. (ERA) has risen 8.00% since March 7, 2017 and is uptrending. It has underperformed by 8.70% the S&P500.

Van Den Berg Management I Inc holds 1.89% of its portfolio in Era Group Inc. for 1.50 million shares. Thomson Horstmann & Bryant Inc owns 563,515 shares or 0.87% of their US portfolio. Moreover, Walthausen & Co. Llc has 0.76% invested in the company for 730,086 shares. The Florida-based Thomas J. Herzfeld Advisors Inc. has invested 0.11% in the stock. Botty Investors Llc, a Illinois-based fund reported 28,809 shares.

Since January 9, 2018, it had 0 insider buys, and 5 insider sales for $2.87 million activity. Shares for $216,956 were sold by Sandrock Alfred on Tuesday, February 20. On Tuesday, January 9 PANGIA ROBERT W sold $1.92M worth of Biogen Inc. (NASDAQ:BIIB) or 5,832 shares.

Investors sentiment increased to 1.17 in 2017 Q3. Its up 0.04, from 1.13 in 2017Q2. It is positive, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Legacy Private Trust has invested 0.08% in Biogen Inc. (NASDAQ:BIIB). Cypress Asset Inc Tx has invested 0.11% in Biogen Inc. (NASDAQ:BIIB). Salient Tru Company Lta holds 0.53% in Biogen Inc. (NASDAQ:BIIB) or 14,245 shares. 2,394 were accumulated by Brown Cap Ltd Liability. The Pennsylvania-based Federated Invsts Pa has invested 0% in Biogen Inc. (NASDAQ:BIIB). New Amsterdam Prtnrs New York holds 1,471 shares or 0.1% of its portfolio. Natl Planning, a California-based fund reported 1,765 shares. Waters Parkerson & Ltd Limited Liability Company reported 0.02% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Moreover, Ajo Lp has 0.16% invested in Biogen Inc. (NASDAQ:BIIB) for 115,564 shares. X Management Ltd Llc, New York-based fund reported 3,936 shares. Dnb Asset As reported 0.18% of its portfolio in Biogen Inc. (NASDAQ:BIIB). First Quadrant LP Ca has invested 0.66% in Biogen Inc. (NASDAQ:BIIB). Btim invested in 2,694 shares. Nuveen Asset Mgmt reported 136,382 shares or 0.28% of all its holdings. Hennessy Advisors has 0.07% invested in Biogen Inc. (NASDAQ:BIIB).

Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on April, 24. They expect $5.94 earnings per share, up 14.23% or $0.74 from last year’s $5.2 per share. BIIB’s profit will be $1.26B for 12.04 P/E if the $5.94 EPS becomes a reality. After $5.26 actual earnings per share reported by Biogen Inc. for the previous quarter, Wall Street now forecasts 12.93% EPS growth.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: